EMD-45624

Single-particle
3.0 Å
EMD-45624 Deposition: 05/07/2024
Map released: 25/09/2024
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-45624

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9cj7 summary report (pdf.gz) Map-9cj7 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Lineage IV Lassa virus glycoprotein (Josiah) in complex with monoclonal antibody 8.9F

EMD-45624

Single-particle
3.0 Å
EMD-45624 Deposition: 05/07/2024
Map released: 25/09/2024
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Lassa virus Josiah, Homo sapiens, Oryctolagus cuniculus
Sample: Lineage IV Lassa virus glycoprotein (Josiah) in complex with monoclonal antibody 8.9F
Fitted models: 9cj7

Deposition Authors: Brouwer PJM, Perrett HR , Ward AB
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responses.
PUBMED: 39243373
DOI: doi:10.1016/j.celrep.2024.114708
ISSN: 2211-1247